KiRA Biotech
Australia - ToowongBiotechnology
Focus: KiRA Biotech is an Australian-headquartered biotechnology company focused on immune disorder treatments and monoclonal antibody development. As a public-stage company, it operates in the competitive immunology space.
Profile data last refreshed 2h ago · AI intelligence enriched 2mo ago
Funding Stage
PUBLIC
Open Jobs
19+19 this month
Growing — net +19 jobs in 30d
26 jobs added vs 7 removed. Steady team buildout.
Should You Work at KiRA Biotech?
AI assessmentKiRA Biotech presents a speculative career opportunity with strong immunology focus but significant transparency gaps that warrant deep due diligence before commitment.
Why Work Here
- Specialized focus on monoclonal antibody therapeutics in immune disorders offers deep technical expertise in a high-demand modality
- Public company status provides liquidity and established corporate infrastructure versus pre-revenue biotech risk
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for KiRA Biotech
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.